Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner.

作者: Kailiang Zhang , Xiaotian Sun , Xuan Zhou , Lei Han , Luyue Chen

DOI: 10.18632/ONCOTARGET.2681

关键词:

摘要: The long non-coding RNA Hox transcript antisense intergenic (HOTAIR) was recently implicated in breast cancer metastasis and is predictive of poor prognosis colorectal pancreatic cancers. We discovered that HOTAIR a cell cycle-related lncRNA human glioma, its expression closely associated with glioma staging prognosis. Although lysine specific demethylase 1 (LSD1) polycomb repressive complex 2 (PRC2) have been demonstrated to be functional targets HOTAIR, how regulates cycle progression remains largely unknown. In this study, we found EZH2 (predominant PRC2 component) inhibition blocked cells, consistent the effects elicited by siRNA. However, LSD1 did not affect cells. These results suggest might regulate through EZH2. Our intracranial mice model also revealed delayed tumor growth siRNA- inhibitor-treated groups. Moreover, knock-down lines, PRC2-binding domain (5' domain) but LSD1-binding (3' resulted accelerated progression. conclusion, promotes as result binding 5' complex.

参考文章(40)
Sean R. Eddy, Non-coding RNA genes and the modern RNA world. Nature Reviews Genetics. ,vol. 2, pp. 919- 929 ,(2001) , 10.1038/35103511
F. Orzan, S. Pellegatta, P. L. Poliani, F. Pisati, V. Caldera, F. Menghi, D. Kapetis, C. Marras, D. Schiffer, G. Finocchiaro, Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Neuropathology and Applied Neurobiology. ,vol. 37, pp. 381- 394 ,(2011) , 10.1111/J.1365-2990.2010.01132.X
Mark E. Oppenlander, Andrew B. Wolf, Laura A. Snyder, Robert Bina, Jeffrey R. Wilson, Stephen W. Coons, Lynn S. Ashby, David Brachman, Peter Nakaji, Randall W. Porter, Kris A. Smith, Robert F. Spetzler, Nader Sanai, An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity: Clinical article Journal of Neurosurgery. ,vol. 120, pp. 846- 853 ,(2014) , 10.3171/2013.12.JNS13184
Lars Henning Schmidt, Tilmann Spieker, Steffen Koschmieder, Julia Humberg, Dominik Jungen, Etmar Bulk, Antje Hascher, Danielle Wittmer, Alessandro Marra, Ludger Hillejan, Karsten Wiebe, Wolfgang E. Berdel, Rainer Wiewrodt, Carsten Muller-Tidow, The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. Journal of Thoracic Oncology. ,vol. 6, pp. 1984- 1992 ,(2011) , 10.1097/JTO.0B013E3182307EAC
Sooryanarayana Varambally, Saravana M. Dhanasekaran, Ming Zhou, Terrence R. Barrette, Chandan Kumar-Sinha, Martin G. Sanda, Debashis Ghosh, Kenneth J. Pienta, Richard G. A. B. Sewalt, Arie P. Otte, Mark A. Rubin, Arul M. Chinnaiyan, The polycomb group protein EZH2 is involved in progression of prostate cancer Nature. ,vol. 419, pp. 624- 629 ,(2002) , 10.1038/NATURE01075
Lingeng Lu, Guangjian Zhu, Chong Zhang, Qian Deng, Dionyssios Katsaros, Susan T. Mayne, Harvey A. Risch, Lina Mu, Emilie Marion Canuto, Gianluca Gregori, Chiara Benedetto, Herbert Yu, Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer Breast Cancer Research and Treatment. ,vol. 136, pp. 875- 883 ,(2012) , 10.1007/S10549-012-2314-Z
Dawn M. Z. Schmidt, Dewey G. McCafferty, trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. Biochemistry. ,vol. 46, pp. 4408- 4416 ,(2007) , 10.1021/BI0618621
Derek R. Johnson, Brian Patrick O’Neill, Glioblastoma survival in the United States before and during the temozolomide era. Journal of Neuro-oncology. ,vol. 107, pp. 359- 364 ,(2012) , 10.1007/S11060-011-0749-4
Raphael Margueron, Guohong Li, Kavitha Sarma, Alexandre Blais, Jiri Zavadil, Christopher L. Woodcock, Brian D. Dynlacht, Danny Reinberg, Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Molecular Cell. ,vol. 32, pp. 503- 518 ,(2008) , 10.1016/J.MOLCEL.2008.11.004